3-iodobenzylguanidine has been researched along with Fibrosarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anton, M; Bodenstein, C; Bönisch, H; Essien, BE; Gansbacher, B; Haubner, R; Schwaiger, M; Wagner, B; Weber, WA | 1 |
| Hill, RP; Kalliomäki, T | 1 |
2 other study(ies) available for 3-iodobenzylguanidine and Fibrosarcoma
| Article | Year |
|---|---|
Use of the norepinephrine transporter as a reporter gene for non-invasive imaging of genetically modified cells.
Topics: 3-Iodobenzylguanidine; Animals; Carcinoma; DNA, Complementary; Fibrosarcoma; Gene Expression Profiling; Gene Transfer Techniques; Genes, Reporter; Hydrogen-Ion Concentration; Mice; Mice, Nude; Norepinephrine Plasma Membrane Transport Proteins; PC12 Cells; Radionuclide Imaging; Radiopharmaceuticals; Rats; Retroviridae; Symporters; Transduction, Genetic; Transplantation, Heterologous; Tumor Cells, Cultured | 2004 |
Effects of tumour acidification with glucose+MIBG on the spontaneous metastatic potential of two murine cell lines.
Topics: 3-Iodobenzylguanidine; Animals; Cell Hypoxia; Female; Fibrosarcoma; Glucose; Hydrogen-Ion Concentration; Male; Melanoma, Experimental; Mice; Neoplasm Metastasis; Tumor Cells, Cultured | 2004 |